Zhi Biology 362 million to build the vaccine industry chain

Zhi Biology (300122) March 8 Evening announcement, the company intends to implement the Ac-hib triple combined vaccine Industrialization Project in the Beijing Economic and Technological Development Zone X53F2 block. Project total investment of 362 million yuan, by the wholly-owned subsidiary of Beijing Green Bamboo for the implementation of the main body.　　The company said that after the project was put into operation, the large-scale production of "a group, C Group of epidemic cerebrospinal meningitis, Hib triple combination vaccine", the company will become the largest and most varieties of meningococcal polysaccharide vaccine and the combination of vaccine manufacturing suppliers. The company's annual report shows that the total operating income of the company in 2010 amounted to 737 million yuan, an increase of 22.06% per cent, the net profit of the shareholders of the listed company is 256 million yuan, the year-on-year increase of 10.88%;　　The company intends to distribute the cash dividend of 2.00 yuan (including tax) for every 10 shares of all shareholders. Responsible Editor: NF054